Fig. 4From: FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinomaThe relationship between FANCD2 and cancer prognosis. FANCD2 univariate cox analysis in different cancers (A) and Hepatitis B-related hepatocellular carcinoma (B). C FANCD2 and clinical characteristics multivariate cox analysis in Hepatitis B-related liver cancerBack to article page